Robert Lundholm
Psychiatric/Mental Health · Omaha, NENPI 1356627244
Payments from drug & device makers
Across 774 payments — averaging $15.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$1K
- Alkermes, Inc.$904
- Otsuka America Pharmaceutical, Inc.$759
- Vanda Pharmaceuticals Inc.$744
- Harmony Biosciences LLC$657
- plus $6K from 28 others
What the payments were for
- Food & beverage$11,95498%
- Education$2322%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 161 | $1,977 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 76 | $1,177 |
| Alkermes, Inc. | 61 | $904 |
| Otsuka America Pharmaceutical, Inc. | 45 | $759 |
| Vanda Pharmaceuticals Inc. | 35 | $744 |
| Harmony Biosciences LLC | 40 | $657 |
| Johnson & Johnson | 34 | $628 |
| Lundbeck LLC | 40 | $620 |
| Teva Pharmaceuticals USA, Inc. | 35 | $543 |
| Axsome Therapeutics, Inc. | 28 | $460 |
| Takeda Pharmaceuticals U.S.A., Inc. | 31 | $438 |
| Supernus Pharmaceuticals, Inc. | 19 | $416 |
| Corium, LLC | 24 | $375 |
| Jazz Pharmaceuticals Inc. | 21 | $367 |
| Ironshore Pharmaceuticals Inc. | 17 | $277 |
| Sunovion Pharmaceuticals Inc. | 14 | $241 |
| E.r. Squibb & Sons, L.L.C. | 13 | $233 |
| Tris Pharma Inc | 10 | $192 |
| Neurocrine Biosciences, Inc. | 9 | $171 |
| Bausch Health US, LLC | 8 | $154 |
| Neos Therapeutics, LP | 9 | $137 |
| Almatica Pharma LLC | 8 | $126 |
| Idorsia Pharmaceuticals US Inc | 6 | $111 |
| Avanir Pharmaceuticals, Inc. | 6 | $82 |
| Collegium Pharmaceutical, Inc. | 4 | $73 |
| Eisai Inc. | 4 | $58 |
| Noven Therapeutics, LLC | 3 | $48 |
| Alfasigma USA, Inc. | 2 | $42 |
| Biogen | 2 | $38 |
| Adlon Therapeutics L.p. | 2 | $33 |
| Pfizer | 2 | $31 |
| Arbor Pharmaceuticals, Inc. | 2 | $30 |
| Merck | 2 | $29 |
| Azurity Pharmaceuticals, Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- QELBREE$133
How this compares
$12,186 in reported general payments places this provider in the 95th percentile of 255 psychiatric/mental health providers in Nebraska.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| SpravatoEsketamine Hcl | 20 | $26,412 |
| AuvelityDextromethorphan Hbr/Bupropion | 14 | $14,299 |
| Lurasidone Hcl | 19 | $5,889 |
| VyvanseLisdexamfetamine Dimesylate | 15 | $5,780 |
| Vilazodone Hcl | 16 | $4,987 |
| Lisdexamfetamine Dimesylate | 22 | $4,487 |
| Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine | 39 | $1,830 |
| Dexmethylphenidate Hcl ErDexmethylphenidate Hcl | 21 | $1,825 |
| Bupropion XlBupropion Hcl | 36 | $1,208 |
| Duloxetine Hcl | 28 | $1,004 |
| Armodafinil | 15 | $994 |
| Lamotrigine | 27 | $751 |
| Clonazepam | 70 | $693 |
| Quetiapine Fumarate | 40 | $607 |
| Aripiprazole | 20 | $593 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonSpravato | $628 | $26,41220 claims |
| Axsome Therapeutics, Inc.Auvelity | $460 | $14,29914 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Vyvanse | $438 | $5,78015 claims |
| Almatica Pharma LLCSertraline Hcl | $126 | $8715 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 255 psychiatric/mental health providers in Nebraska.
Other psychiatric/mental health in Omaha
- Janelle HillOmaha$24K
- Kristi BoseOmaha$13K
- Virginia SmithOmaha$11K
- Christina HadleyOmaha$11K
- Julie ZulkoskyOmaha$8K
- John RamseyOmaha$8K
- M Joyce SasseOmaha$7K
- Molly PetersenOmaha$6K
- Salina AndersonOmaha$6K
- Heather WilhelmOmaha$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.